首页> 美国卫生研究院文献>Breast Cancer Research : BCR >Carbonic anhydrase IX and response to postmastectomy radiotherapy in high-risk breast cancer: a subgroup analysis of the DBCG82 b and c trials
【2h】

Carbonic anhydrase IX and response to postmastectomy radiotherapy in high-risk breast cancer: a subgroup analysis of the DBCG82 b and c trials

机译:碳酸酐酶IX和高危乳腺癌对乳房切除术后放疗的反应:DBCG82 b和c试验的亚组分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

IntroductionA significant survival improvement after postmastectomy radiotherapy was identified in the Danish Breast Cancer Cooperative Group (DBCG82) b and c studies and in the British Columbia Randomized Radiation Trial. Recently, potential predictive value regarding response to postmastectomy radiotherapy was reported for carbonic anhydrase (CA) IX in a study (reported in abstract form) that included 160 patients. The purpose of the present study was to examine the importance of CA IX to response to postmastectomy radiotherapy in the larger scaled DBCG82 b and c studies.
机译:简介丹麦乳腺癌合作组织(DBCG82)b和c研究以及不列颠哥伦比亚省随机放射试验确定了乳房切除术后放疗后的显着生存改善。最近,在一项包括160例患者的研究中,报告了碳酸酐酶(CA)IX对乳房切除术后放疗反应的潜在预测价值。本研究的目的是在较大规模的DBCG82 b和c研究中研究CA IX对乳房切除术后放疗反应的重要性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号